Navigation Links
Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study

to moderate adverse events so that the prescribed dose can be maintained whenever possible. However, in some cases, either a dose reduction or interruption of treatment with Gleevec may be necessary

Gleevec tablets should be taken with food and a large glass of water to minimize GI irritation. Gleevec tablets should not be taken with grapefruit juice

Disclaimer

The foregoing release contains forward-looking statements that can be identified by terminology such as "will," "planned," or similar expressions, or by express or implied discussions regarding potential future regulatory submissions, new indications or new labeling for Gleevec, the long-term impact of a patient's use of Gleevec or potential future sales of Gleevec. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that additional regulatory submissions will be made in any particular jurisdictions, or that Gleevec will be approved for any additional indications or labeling in any market. Nor can there be guarantee regarding the long-term impact of a patient's use of Gleevec. Neither can there be any guarantee regarding potential future sales of Gleevec. In particular, management's expectations regarding Gleevec could be affected by, among other things, unexpected clinical trial results, including additional analysis of Gleevec clinical data, and new clinical data; unexpected regulatory actions or delays or government regulation generally; the company's ability to obtain or maintain patent or other proprietary intellectual property protection; competition in general; government, industry, and general public pricing pressures; and other risks and factors referred to in the Company's current Form 20-F on file with the US Securities and Exchange Commission. Should one or
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Protox Announces Positive Clinical Data from Prostate Cancer Study
5. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
Post Your Comments:
(Date:5/22/2015)... -- The Assistance Fund announces the addition of its ... for copay to individuals diagnosed with Melanoma. ... the Melanoma Copay Assistance Program to our portfolio of ... "With each additional program we are closer to achieving ... one is denied access to medications due to an ...
(Date:5/22/2015)...  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), a clinical-stage drug ... today announced that J.J. Finkelstein , chief executive ... overview at two upcoming investor conferences. ... Annual Microcap Conference on Thursday May 28, 2015 ... 11:00 am EDT.  A webcast will be available at ...
(Date:5/22/2015)... May 22, 2015  The Mesothelioma Victims Center ... of mesothelioma get the best possible compensation, and they ... with this rare cancer caused by exposure to ... information related to treatment options such as a ... the Mesothelioma Victims Center anytime at 866-714-6466. ...
Breaking Medicine Technology:The Assistance Fund Adds Melanoma Assistance Program 2RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 5
(Date:5/22/2015)... Power Systems is proud to announce the sponsorship of Elite ... in his second year of racing in the professional division ... Department in Missoula, MT. He entered the triathlon scene in ... he has had 15 1st Place finishes. In his first ... all seven of his 2014 races, including two 2nd Place ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 According to ... hub for drug related death, totaling almost 2,500 confirmed drug ... reported by state officials, totals 2,489 deaths stemming from legal ... out, Pennsylvania loses seven people every day to fatal overdoses ... been singled out as one of the most rife with ...
(Date:5/22/2015)... New York, NY (PRWEB) May 22, 2015 ... abstract entitled “Positivity Rates and Genotype Results in ‘Baby ... Action: Results from a Nationwide Lab Test Database” at Digestive ... conducted by Medivo’s Clinical Affairs and Analytics team members Carol ... Dhaliwal, MD; and Andrea Parker, MSI, along with Nancy Reau, ...
(Date:5/22/2015)... Raton, FL (PRWEB) May 22, 2015 ... which provides vascular, electrocardiogram (EKG), echocardiogram and NCV ... David Sempier, a highly respected All American National athlete, ... multi-sport athlete, I find the high level of testing ... both the athlete and their athletic trainers, this way ...
(Date:5/22/2015)... In an effort to support the athletes of ... donate $5 dollars for every maintenance call, and $25 ... system. Customers have their needs serviced, and donations contributed ... the Special Olympics receives money. Hence the name Everybody ... million athletes, and boasts a myriad of events. This ...
Breaking Medicine News(10 mins):Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2Health News:Medivo Study Finds HCV Positivity Rates are 250% Higher Among Baby Boomers 2Health News:Wimbledon Athletics Recruits Team USA Athlete 2Health News:Wimbledon Athletics Recruits Team USA Athlete 3Health News:Parker and Sons is Proud to Support the Special Olympics with Their Everybody Wins Program 2
... (MRI) technique called arterial spin can distinguish// between ... is often mistaken for Alzheimer’s disease in patients ... its behavior manifestations. The disease is characterized by ... repetitive or compulsive behavior, lack of inhibition or ...
... of new disease like SARS, Ebola, Marburg and Avian influenza ... from a global perspective. ,In an article in the ... suggested that instead of tackling these epidemics from the standpoint ... tackled with a common health program for the entire world. ...
... licensed the use of strontium ranelate to be used for ... the drug it is important to observe the changes in ... Medical Journal has said that the drug strontium ranelate have ... this effect can be used in advantage of the treatment ...
... children in the age group of 4 to 6 years of ... single helping. ,New research on pediatric behavior suggests that preschool ... in any one time. Till date it was accepted that these ... last meals, or how calorie rich the last meals were. New ...
... in maintaining the proper structure// and function of cell ... In fact animal studies have shown that high intake ... A cataract is a clouding of the normally clear ... leading cause of blindness in the world today. Besides ...
... anti cancer drug that is used to treat cancers of ... labor. The drug acts on the function of a hormone ... process of delivery. ,Researchers from the University of Newcastle ... also known as TSA, affects the human smooth muscle cells ...
Cached Medicine News:Health News:PUFA reduces risk of cataract 2
... pause of a heartbeat. The bodys warmth ... breathing. These vital signs are yours to ... line of Temperature Monitoring products helps you ... needed to provide the most comfortable and ...
... is a portable, compact, lightweight system with ... emitting the same intensity (50 mW/cm) of ... smaller treatment area (30 cm). Excilite- possesses ... satisfy the most demanding professional users. The ...
... HIRO 3.0 is the most advanced system for ... system features a patented optical fiber handpiece that ... precision, recovering up to the 20% of the ... are averted thanks to a special gel which ...
... which can remove any undesired hair (except ... of large areas thus reducing operating time. ... light system for faster and extensive treatments ... skins. These characteristics make it a real ...
Medicine Products: